Innoviva, Inc. (INVA)
19.74
0.00 (0.00%)
USD |
NASDAQ |
Jan 15, 16:00
19.74
0.00 (0.00%)
After-Hours: 20:00
Innoviva SG&A Expense (TTM): 112.52M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.976B |
| Eli Lilly & Co. | 10.39B |
| Merck & Co., Inc. | 10.70B |
| Axsome Therapeutics, Inc. | 514.57M |
| Keros Therapeutics, Inc. | 45.77M |